Celebrating 250 Years of Innovation in America
By: Priscilla VanderVeer
As we celebrate 250 years of American independence, we're also celebrating something that has transformed and saved countless lives: America's unparalleled record of medical innovation.
For generations, the United States has led the world in discovering, developing, and delivering breakthrough medicines and technologies that have changed what is possible for people fighting disease. That leadership wasn't inevitable. It was built through decades of scientific curiosity, entrepreneurial risk-taking, and policies that rewarded those brave enough to innovate.
Building the foundation for medical discovery
America's commitment to medical discovery predates the nation itself.
The College of Philadelphia, now known as the University of Pennsylvania, created a medical school in 1765, with three more to follow before the year 1800 at Columbia, Harvard, and Dartmouth.
And in the 1800s, American innovators pushed medicine forward through advances that changed the course of history, such as anesthesia practices that made surgery safer. This era also saw the trailblazing leadership of physicians from diverse backgrounds. Elizabeth Blackwell became the first American woman to earn a medical degree, and David Jones Peck became the first African American medical school graduate.
Preventing and treating disease
America began to establish itself as a medical powerhouse in the 20th century.
Vaccines for whooping cough, polio, measles, and many other infectious diseases came out of American labs. These breakthroughs dramatically reduced illness and death and fundamentally changed public health, allowing us to live longer, healthier lives.
Meanwhile, Dr. Joseph Murray performed the first successful kidney transplant in Boston in 1954, and then went on to pioneer the use of immunosuppressants to allow donor transplants to succeed without rejection.
In the latter part of the 20th century, researchers in California developed the first synthetic insulin genetically engineered to match human DNA, marking a major advancement for diabetes patients who had previously been using insulin extracted from animals.
Beyond the lab
American innovation is renowned for expanding beyond the lab, too.
Although penicillin was first discovered in Europe, American scientists, manufacturers, and government leaders rapidly increased production during World War II from millions to hundreds of billions of units, making penicillin the war's "miracle drug" by treating infected battlefield wounds and saving countless lives. After the war, that manufacturing capacity was redirected to civilian medicine, fueling the growth of the U.S. pharmaceutical industry, accelerating the development of new antibiotics and medicines, and helping lay the foundation for America's modern biotechnology ecosystem.
In 1965, groundbreaking government programs known as Medicare and Medicaid helped ensure that America's medical breakthroughs could reach more patients, extending health coverage to older adults, people with disabilities, and low-income families. Today, these landmark programs serve more than 130 million Americans, making access to care possible for millions who might otherwise go without.
Even our space program helped accelerate innovation in healthcare. The telemetry systems developed during the Gemini and Apollo missions to monitor astronauts' heart rate, breathing, and other vital signs became the foundation for modern remote patient monitoring. Today, those pioneering technologies have evolved into the cardiac monitors, wearable devices, and continuous monitoring systems that help clinicians track patients in hospitals and at home, improving care and saving lives.
Turning scientific breakthroughs into lifesaving care
Today, America continues to redefine what's possible.
The United States played a leading role in the Human Genome Project, one of the most ambitious scientific endeavors in history. Completed in 2003, the project produced the first complete map of the human genome, fundamentally changing how scientists understand disease and launching the era of precision medicine. Today, advances in genomic sequencing continue to accelerate breakthroughs in cancer, rare diseases, and many other conditions.
Recently, American companies used mRNA technology during the COVID-19 pandemic to develop vaccines, and are now advancing new vaccines and cancer treatments. And just last month, a clinical trial showed that a first-in-class targeted oral therapy doubled overall survival for patients with pancreatic cancer, offering new hope against one of the deadliest forms of cancer and demonstrating the power of precision medicine to transform lives.
And this pace of innovation extends well beyond cancer. GLP-1 medicines have reshaped endocrinology and weight management, significantly impacting obesity-related diseases. These advances remind us that the next generation of cures is already within reach if we continue to foster an environment where innovation can thrive.
The next generation of medicine
The next 250 years of American innovation begin with the choices we make today. America's history shows what is possible when bold science, the entrepreneurial spirit, and smart public policy work together.
As we look back on our remarkable history, we should also look ahead with renewed determination to preserve America's leadership for the next 250 years. If we continue incentivizing this great ecosystem, just imagine the cures we'll celebrate in the milestone anniversaries to come.